PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Chordia Therapeutics Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (9)

Chordia Therapeutics Inc. made a loss over the last year. Chordia Therapeutics Inc. owes ¥0.10 for every ¥1 it owns. Chordia Therapeutics Inc. made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Aug 2025.

P/E ratio

Loss

Chordia Therapeutics Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.61

The share price is 1.61 times Chordia Therapeutics Inc.'s book value per share, higher than 53% of Healthcare companies in Japan.

Market cap

¥3.8 B

The total market value of all of Chordia Therapeutics Inc.'s shares at today's price (share price × number of shares), smaller than 85% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥2.3 B

What Chordia Therapeutics Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 May 2026).

Book value per share

¥31.02

Net worth divided by the number of shares. The share price of ¥50.00 is 1.6 times this, which is the P/B above.

Return on equity (ROE)

-66.7%

Chordia Therapeutics Inc. lost 66.7% of its shareholders' money over the last year, lower than 92% of Healthcare companies in Japan.

Owes vs Owns

0.10×

Chordia Therapeutics Inc. owes ¥0.10 for every ¥1 it owns (low), lower than 93% of Healthcare companies in Japan.

Dividend yield

None

Chordia Therapeutics Inc. does not currently pay a dividend.

Profit growth

Loss

Chordia Therapeutics Inc. made a loss in each of the last two years.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Chordia Therapeutics Inc.: ¥3.8 B ÷ ¥2.3 B (31 May 2026) = 1.6.

What is Chordia Therapeutics Inc.'s return on equity?

Chordia Therapeutics Inc. lost 66.7% of its shareholders' money over the last year, lower than 92% of Healthcare companies in Japan.

How much does Chordia Therapeutics Inc. owe compared with what it owns?

Chordia Therapeutics Inc. owes ¥0.10 for every ¥1 it owns (low), lower than 93% of Healthcare companies in Japan.

Does Chordia Therapeutics Inc. pay a dividend?

No. Chordia Therapeutics Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.